Fixed combination of highly selective β-adrenoblocker bisoprolol and calcium antagonist amlodipine (Concor® AM) for arterial hypertension treatment in metabolic disorder patients

Fixed combination of highly selective β-adrenoblocker bisoprolol and calcium antagonist amlodipine (Concor® AM) for arterial hypertension treatment in metabolic disorder patients

Introduction. Combination therapy is widely used in treatment of patients with arterial hypertension (AH) of high and very high cardiovascular risk. Fixed combinations (FC) of medications are preferable and it is important to develop new effective and safe ones. Organ-protective effects are also sig...

Full description

Bibliographic Details
Main Authors: Zhernakova Yu.V., Martyniuk T.V., Arkhipova O.A.
Format: Article
Language:Russian
Published: IP Morozov P.V. 2017-02-01
Series:Системные гипертензии
Subjects:
arterial hypertension
metabolic syndrome
antihypertensive therapy
combined therapy
Online Access:http://syst-hypertension.ru/en/archive/2017/vol-14-1-2017/fixed-combination-of-highly-selective-adrenoblocker-bisoprolol-and-calcium-antagonist-amlodipine-con_1796/

Internet

http://syst-hypertension.ru/en/archive/2017/vol-14-1-2017/fixed-combination-of-highly-selective-adrenoblocker-bisoprolol-and-calcium-antagonist-amlodipine-con_1796/

Similar Items